Evidence map›Paper›PMID 39160608›Full record

ArticleParasites & vectors2024

Veterinary perspectives on the urbanization of leishmaniosis in Morocco.

Clara M Lima, Maria Bourquia, Abderrahmane Zahri, Nada Haissen, Nuno Santarém, Luís Cardoso, Anabela Cordeiro da Silva

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clara M Lima *Host-Parasite Interaction Group, i3S, Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Maria Bourquia *Unité de Parasitologie et Maladies Parasitaires, Département de Pathologie et Santé Publique Vétérinaires, Institut Agronomique et Vétérinaire Hassan II, Rabat, Morocco.
Abderrahmane ZahriUnité de Parasitologie et Maladies Parasitaires, Département de Pathologie et Santé Publique Vétérinaires, Institut Agronomique et Vétérinaire Hassan II, Rabat, Morocco.
Nada HaissenUnité de Parasitologie et Maladies Parasitaires, Département de Pathologie et Santé Publique Vétérinaires, Institut Agronomique et Vétérinaire Hassan II, Rabat, Morocco.
Nuno SantarémHost-Parasite Interaction Group, i3S, Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Luís CardosoDepartment of Veterinary Sciences, and Animal and Veterinary Research Centre (CECAV), University of Trás-os-Montes e Alto Douro, Vila Real, Portugal. lcardoso@utad.pt.
Anabela Cordeiro da SilvaHost-Parasite Interaction Group, i3S, Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.

Funding

Fundação para a Ciência e a Tecnologia 2020. 07306.BDFundação para a Ciência e a Tecnologia PTDC/CVT-CVT/6798/2020
6 · The paper itself

Abstract

backgroundLeishmaniosis caused by Leishmania infantum, L. major and L. tropica is endemic in Morocco. Growing evidence of both human and canine Leishmania infections in urban centres has been reported. Since many forms of the disease are zoonotic, veterinarians play an important role in leishmaniosis control by intervening at the parasite host level. This study aimed to bring together One Health principles to connect canine and feline leishmaniosis epidemiology within urban centres of Morocco (Rabat and Fez) and assess the level of awareness of Moroccan veterinarians about facing this threat.

methodsA molecular survey was conducted for Leishmania DNA detection in canine (n = 155) and feline (n = 32) whole-blood samples. Three conventional polymerase chain reaction (PCR) protocols were implemented. The first PCR aimed at identifying infected animals by targeting Leishmania spp. kinetoplast minicircle DNA (kDNA). The second and third PCR targeted the Leishmania internal transcribed spacer region (ITS-1) and the Leishmania small subunit ribosomal RNA (SSUrRNA) gene, respectively, aiming at identification of the infecting species after Sanger sequencing-positive amplicons. Total immunoglobulin G (IgG) against Leishmania spp. was evaluated in 125 dogs by enzyme-linked immunosorbent assays (ELISA) using an in-house protocol, including three Leishmania-specific antigens (SPLA, rKDDR and LicTXNPx). Sera from 25 cats were screened for total IgG to Leishmania spp. by an indirect immunofluorescence antibody test (IFAT). An online questionnaire was presented to Moroccan veterinarians addressing their knowledge and practices towards animal leishmaniosis.

resultsOverall, 19.4% of the dogs tested positive for Leishmania kDNA and ITS-1 and sequencing revealed infection with L. infantum among PCR-positive dogs. These animals presented a wide range of ELISA seropositivity results (16.7%, 34.9% and 51.6%) according to the tested antigens (rKDDR, SPLA and LicTXNPx, respectively). Use of kDNA-PCR revealed 12.5% cats positive to Leishmania spp. otherwise found to be seronegative by IFAT.

conclusionsA considerable prevalence of infection was identified in dogs from urban centres of Morocco. Additionally, this is the first report of feline infection with Leishmania spp. in this country and in urban settings. Moroccan veterinarians are aware that animal leishmaniosis is endemic in Morocco, representing a public health threat, and are knowledgeable about canine leishmaniosis diagnosis and treatment.

Indexed as

Cat DiseasesDog DiseasesLeishmaniasisAnimalsAntibodies, ProtozoanCatsDNA, ProtozoanDogsFemaleHumansImmunoglobulin GLeishmaniaLeishmania infantumMaleMoroccoPolymerase Chain ReactionAntibodies, ProtozoanDNA, ProtozoanImmunoglobulin GELISALeishmaniosisLicTXNPxMoroccoOne HealthPCRrKDDR-ELISASPLA-ELISASurveyVeterinarians

Identifiers

PMID39160608
PMCPMC11334585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.